XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues:        
Total revenues $ 40,991 $ 35,131 $ 83,457 $ 71,670
Costs and expenses:        
Cost of sales 4,772 4,528 10,239 8,723
Research and development expenses 503 0 503 0
Selling, general and administrative expenses 16,771 10,543 33,675 21,184
Change in fair value of contingent consideration 241 1,300 9,408 2,945
Amortization of intangible assets 6,284 7,969 12,568 16,469
Total costs and expenses 28,571 24,340 66,393 49,321
Income from operations 12,420 10,791 17,064 22,349
Other (expense) income:        
Debt-related expenses 0 0 (9,918) 0
Interest expense 751 2,269 1,873 4,596
Other gain (loss) 661 (95) 1,463 451
Total other expense (90) (2,364) (10,328) (4,145)
Net income before income taxes 12,330 8,427 6,736 18,204
Income tax expense (3,860) (593) (1,750) (1,306)
Net income and comprehensive income 8,470 7,834 4,986 16,898
Net income and comprehensive income $ 8,470 $ 7,834 $ 4,986 $ 16,898
Basic net income per share (in dollars per share) $ 0.15 $ 0.17 $ 0.09 $ 0.37
Diluted net income per share (in dollars per share) $ 0.13 $ 0.16 $ 0.09 $ 0.36
Shares used in computing basic net income per share (in shares) 56,142 46,274 53,588 45,746
Shares used in computing diluted net income per share (in shares) 70,144 47,579 58,010 46,857
Product sales, net        
Revenues:        
Total revenues $ 40,083 $ 35,430 $ 81,852 $ 70,977
Royalties and milestones        
Revenues:        
Total revenues 723 451 1,420 1,443
Other revenue        
Revenues:        
Total revenues $ 185 $ (750) $ 185 $ (750)